The chronic nature of psoriasis means that patients often require lifetime treatment. Over this time, treatment frequentlyhas to be adapted to meet variable demands resulting from changes in life course and life events. Biological drugs usedto treat psoriasis vary in their dosing regimens, convenience and flexibility. Dermatologists need to understand whichbiologic agent is best suited for each individual patient. A wealth of evidence supports the safe and effective use of etanercept,which offers a rapid and sustained response, flexibility of dosing, maintenance of response after dose reductionor interruption, and efficacy against non-skin manifestations such as psoriatic arthritis. An expert panel met to agree thetypical patient profile of a psoriasis patient treated with etanercept, the main benefits of etanercept in psoriasis, and thepatient group most likely to benefit from its use. They agreed that flexibility of dosing, the potential to individualize therapyby stopping and starting treatment while maintaining efficacy, and the possibility of cost saving through the use offlexible treatment regimens were important benefits supporting the use of etanercept in many patients with psoriasis.

Treatment of psoriasis with etanercept: the typical patient profile

GIROLOMONI, Giampiero
2016-01-01

Abstract

The chronic nature of psoriasis means that patients often require lifetime treatment. Over this time, treatment frequentlyhas to be adapted to meet variable demands resulting from changes in life course and life events. Biological drugs usedto treat psoriasis vary in their dosing regimens, convenience and flexibility. Dermatologists need to understand whichbiologic agent is best suited for each individual patient. A wealth of evidence supports the safe and effective use of etanercept,which offers a rapid and sustained response, flexibility of dosing, maintenance of response after dose reductionor interruption, and efficacy against non-skin manifestations such as psoriatic arthritis. An expert panel met to agree thetypical patient profile of a psoriasis patient treated with etanercept, the main benefits of etanercept in psoriasis, and thepatient group most likely to benefit from its use. They agreed that flexibility of dosing, the potential to individualize therapyby stopping and starting treatment while maintaining efficacy, and the possibility of cost saving through the use offlexible treatment regimens were important benefits supporting the use of etanercept in many patients with psoriasis.
2016
psoriasis,etanercept
File in questo prodotto:
File Dimensione Formato  
Prinz Treatment of pso with etanercept typical patient profile. JEADV 2016.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Accesso ristretto
Dimensione 96.7 kB
Formato Adobe PDF
96.7 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/944834
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 15
social impact